Radiosensitization induced by the anti-epidermal growth factor receptor monoclonal antibodies cetuximab and nimotuzumab in A431 cells

Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance

(2015) Kimmo J. Hatanpaa et al.   NEOPLASIA

Bivalent binding by intermediate affinity of nimotuzumab: A contribution to explain antibody clinical profile

(2011) Greta Garrido et al.   CANCER BIOLOGY & THERAPY

Histone  H2AX and Poly(ADP-Ribose) as Clinical Pharmacodynamic Biomarkers

(2010) C. E. Redon et al.   CLINICAL CANCER RESEARCH

Nimotuzumab for pediatric diffuse intrinsic pontine gliomas

(2010) Maura Massimino et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Induction of γ-H2AX foci in human exfoliated buccal cells after in vitro exposure to ionising radiation

(2010) Jorge E. González et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

An application of compound Poisson modelling to biological dosimetry

(2010) P. Puig et al.   PROCEEDINGS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES

Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status

(2008) Y Akashi et al.   BRITISH JOURNAL OF CANCER

Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer

(2008) David I. Pryor et al.   RADIOTHERAPY AND ONCOLOGY

The buccal cytome and micronucleus frequency is substantially altered in Down's syndrome and normal ageing compared to young healthy controls

(2007) Philip Thomas et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS